4//SEC Filing
BENOLIEL D JEFFRY 4
Accession 0001209191-18-032600
CIK 0000081362other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:26 PM ET
Size
36.6 KB
Accession
0001209191-18-032600
Insider Transaction Report
Form 4
BENOLIEL D JEFFRY
VP-Global Strategy, GC & Sec
Transactions
- Gift
Common Stock
2018-05-07−140→ 11,531 total - Sale
Common Stock
2018-05-21$157.01/sh−1,472$231,115→ 11,531 total - Exercise/Conversion
Employee Stock Option (right to buy)
2018-05-21−1,472→ 0 totalExercise: $73.47Exp: 2021-02-27→ Common Stock (1,472 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2018-05-21−1,488→ 0 totalExercise: $87.30Exp: 2022-02-25→ Common Stock (1,488 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2018-05-21−2,426→ 1,213 totalExercise: $72.12Exp: 2023-02-23→ Common Stock (2,426 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2018-05-21−730→ 1,458 totalExercise: $134.60Exp: 2024-02-27→ Common Stock (730 underlying) - Gift
Common Stock
2018-04-13−750→ 11,671 total - Gift
Common Stock
2018-04-18+20→ 10,620 total(indirect: Custodial Account for Son DJ) - Gift
Common Stock
2018-04-18+20→ 10,620 total(indirect: Custodial Account for Daughter) - Exercise/Conversion
Common Stock
2018-05-21$73.47/sh+1,472$108,148→ 13,003 total - Exercise/Conversion
Common Stock
2018-05-21$87.30/sh+1,488$129,902→ 13,019 total - Sale
Common Stock
2018-05-21$157.01/sh−1,488$233,633→ 11,531 total - Exercise/Conversion
Common Stock
2018-05-21$72.12/sh+2,426$174,963→ 13,957 total - Sale
Common Stock
2018-05-21$157.00/sh−2,426$380,892→ 11,531 total - Exercise/Conversion
Common Stock
2018-05-21$134.60/sh+730$98,258→ 12,261 total - Sale
Common Stock
2018-05-21$157.00/sh−730$114,610→ 11,531 total
Holdings
- 17,020(indirect: By Partnership)
Common Stock
- 10,451(indirect: By 401(k))
Common Stock
- 10,600(indirect: Custodial Account for Son PA)
Common Stock
- 10,000(indirect: By Trust)
Common Stock
- 9,732(indirect: By Trust)
Common Stock
Footnotes (8)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.00 to $157.0950, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.00 to $157.0650, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.00 to $157.0550, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]Information based on reporting person's Plan Statement as of March 31, 2018.
- [F5]The options for this grant vested in three annual installments: 737 shares on February 27, 2015; 736 shares on February 27, 2016; and 736 shares on February 27, 2017.
- [F6]The options for this grant vested in three annual installments: 745 shares on February 25, 2016; 744 shares on February 25, 2017; and 744 shares on February 25, 2018.
- [F7]The options for this grant vest in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019.
- [F8]The options for this grant vest in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020.
Documents
Issuer
QUAKER CHEMICAL CORP
CIK 0000081362
Entity typeother
Related Parties
1- filerCIK 0001238122
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:26 PM ET
- Size
- 36.6 KB